Immunotherapy has revolutionized cancer treatment by harnessing the power of T cells to attack tumors. But, even when these treatments are successful, scientists often struggle to understand exactly ...
Dendritic cell receptors, in particular C‐type lectins such as DC-SIGN, play a pivotal role in the immune response by recognising and internalising diverse glycan structures present on pathogens. The ...
The research, backed by the National Institutes of Health, could one day lead to new treatments for cancer and a range of inflammatory diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback